Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
YUMANITY THERAPEUTICS, INC. | SVP and General Counsel | Common Stock | 14K | $62.8K | $4.50 | Dec 2, 2022 | Direct |
IO Biotech, Inc. | General Counsel | Common Stock | 4.94K | $5.11K | $1.04 | Aug 9, 2023 | Direct |
IO Biotech, Inc. | General Counsel | Stock Option (Right to Buy) | 185K | Mar 15, 2024 | Direct | ||
IO Biotech, Inc. | General Counsel | Warrants (Right to Buy) | 4.94K | Aug 9, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IOBT | IO Biotech, Inc. | Mar 15, 2024 | 1 | $0 | 4 | Mar 18, 2024 | General Counsel |
IOBT | IO Biotech, Inc. | Aug 9, 2023 | 2 | $10K | 4 | Aug 9, 2023 | General Counsel |
IOBT | IO Biotech, Inc. | Jan 12, 2023 | 1 | $0 | 4 | Jan 13, 2023 | General Counsel |
IOBT | IO Biotech, Inc. | Jan 3, 2023 | 0 | $0 | 3 | Jan 13, 2023 | General Counsel |
KA | YUMANITY THERAPEUTICS, INC. | Dec 2, 2022 | 1 | -$5.27K | 4 | Dec 6, 2022 | SVP and General Counsel |
KA | YUMANITY THERAPEUTICS, INC. | Jun 3, 2022 | 1 | -$3.49K | 4 | Jun 6, 2022 | SVP and General Counsel |
KA | YUMANITY THERAPEUTICS, INC. | Dec 1, 2021 | 1 | $0 | 4 | Dec 3, 2021 | SVP and General Counsel |
KA | YUMANITY THERAPEUTICS, INC. | Jun 14, 2021 | 1 | $0 | 4 | Jun 16, 2021 | SVP and General Counsel |
KA | YUMANITY THERAPEUTICS, INC. | Jun 14, 2021 | 0 | $0 | 3 | Jun 16, 2021 | SVP and General Counsel |